Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL745269

CN1C2CCCC1CC(Oc1ccc(-c3ccc4[nH]ccc4c3)nn1)C2.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 11/20 0.50
KCNH2 Q12809 6/20 0.44
CHRNB2 P17787 3/20 0.41
CHRNB4 P30926 3/20 0.41
CHRNA3 P32297 3/20 0.41
CHRNA4 P43681 3/20 0.41
HTT P42858 1/20 0.39
PTGS2 P35354 1/20 0.36
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
GRM2 Q14416 1/20 0.35
IL1B P01584 1/20 0.35
NLRP3 Q96P20 1/20 0.35
PIK3CD O00329 2/20 0.35
ABL1 P00519 1/20 0.35
EGFR P00533 1/20 0.35
HCK P08631 1/20 0.35
SRC P12931 1/20 0.35
KDR P35968 1/20 0.35
PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL744964 0.96 CHRNA7 (0.52) CHRNA7KCNH2CHRNB2CHRNB4CHRNA3
SCHEMBL745841 0.91 CHRNA7 (0.59) CHRNA7KCNH2CHRNB2CHRNB4CHRNA3
Trifluoroacetic Acid SCHEMBL764686 0.90 CHRNA7 (0.44) CHRNA7KCNH2CHRNB2CHRNB4CHRNA3
SCHEMBL745277 0.87 CHRNA7 (0.61) CHRNA7KCNH2CHRNB2CHRNB4CHRNA3
Fumaric Acid SCHEMBL745601 0.86 CHRNA7 (0.52) CHRNA7KCNH2CHRNB2CHRNB4CHRNA3
Trifluoroacetic Acid SCHEMBL747090 0.85 CHRNA7 (0.51) CHRNA7KCNH2HTTIL1BNLRP3
Trifluoroacetic Acid SCHEMBL748481 0.84 CHRNA7 (0.44) CHRNA7KCNH2CHRNB2CHRNB4CHRNA3
Trifluoroacetic Acid SCHEMBL748480 0.84 CHRNA7 (0.44) CHRNA7KCNH2CHRNB2CHRNB4CHRNA3
Trifluoroacetic Acid SCHEMBL745728 0.81 NPC1 (0.38) CHRNA7HTTACACBACACAIL1B
Trifluoroacetic Acid SCHEMBL990814 0.81 CHRNA7 (0.46) CHRNA7KCNH2HTTIL1BNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431368-B1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBVIE BAHAMAS LTD (BS) 2014-08-27 EP disclosed
EP-2431368-A1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives Abbott Laboratories (US) 2012-03-21 EP disclosed
EP-2018380-B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LAB (US) 2011-10-19 EP disclosed
US-7872017-B2 Fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LABORATORIES (US) 2011-01-18 US disclosed
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives ABBOTT LABORATORIES (US) 2010-12-02 US disclosed
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES ABBVIE INC. 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES MALT1, BMP2, ALKBH2 CHRNA7 2776/4885KCNH2 708/4885CHRNB2 2585/4885
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives MALT1, BMP2, ALKBH2 CHRNA7 2776/4885KCNH2 708/4885CHRNB2 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.